Logo
NEOSTIGMINE METHYLSULFATE INJECTION MARKET ANALYSIS
  2. / Market Insights
  3. Neostigmine Methylsulfate Injection Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

NEOSTIGMINE METHYLSULFATE INJECTION MARKET ANALYSIS

Neostigmine Methylsulfate Injection Market, By Dosage (1mg/mL and 0.5 mg/ mL), By Indication (Myasthenia Gravis and Reversal of Neuromuscular Blockade), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End Use (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI6033
  • Pages :150
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Top Companies in the Neostigmine Methylsulfate Injection Market

  • Baxter International Inc.
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Boehringer Ingelheim GmbH
  • Mylan N.V.
  • Novartis International AG
  • Teva Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals PLC
  • GlaxoSmithKline plc
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz (a division of Novartis)
  • Accord Healthcare Inc.
  • Lannett Company, Inc.
  • Mallinckrodt Pharmaceuticals
  • Lupin Limited

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.